Back to Swiss Life Asset Management Ltd Swiss Life Asset Management Ltd

REGN

Showing 9 of 31 quarters

Position history for Swiss Life Asset Management LtdSwiss Life Asset Management Ltd's holdings in Regeneron Pharmaceuticals, Inc.

Yes. Swiss Life Asset Management holds 39,324 shares of REGN (Regeneron Pharmaceuticals), worth $29.8M, as of its Q3 2026 13F filing. It increased the position by 11,104 shares (+39.4%) from Q2 2026. Swiss Life Asset Management has held REGN in every 13F on record since Q1 2019, 31 quarterly filings. REGN is 0.1% of Swiss Life Asset Management's reported 13F portfolio.

Current Value

$29.8M

Current Shares

39,324

Total Value Change

+$19.7M

Total Shares Change

+29,660

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
39,324
+39.4%
$29.8M0.1%$758.27
46
2026-Q2
Decreased
28,220
-7.5%
$17.6M0.1%$622.81
0
2026-Q1
Increased
30,525
+183.6%
$14.1M0.1%$770.59
45
2025-Q4
Decreased
10,762
-54.5%
$8.3M0.0%$768.90
0
2025-Q3
Increased
23,658
+112.0%
$13.3M0.1%$559.40
45
2025-Q2
Increased
11,158
+7.3%
$5.9M0.0%$521.53
29
2025-Q1
Increased
10,404
+13.4%
$6.6M0.0%$629.11
31
2024-Q4
Decreased
9,178
-5.0%
$6.5M0.0%$705.67
0
2024-Q3
Increased
9,664
+21.3%
$10.2M0.1%$1,041.41
40

Other major holders of REGN: FMR LLC, Vanguard Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used